AGM/EGMApr 30, 2026, 05:17 PM
KPRX 2026 Annual Meeting on June 10; Equity Plan Share Increase
AI Summary
Kiora Pharmaceuticals, Inc. filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for June 10, 2026. Stockholders will vote on the election of three Class II directors, an advisory resolution on executive compensation, the ratification of Haskell & White LLP as auditors, and an amendment to increase shares authorized under the 2024 Equity Incentive Plan by 1,500,000 shares. The board recommends voting "FOR" all proposals.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held on Wednesday, June 10, 2026.
- Stockholders to elect three Class II Directors for a three-year term.
- Non-binding advisory vote on named executive officer compensation.
- Ratification of Haskell & White LLP as independent auditor for fiscal year 2026.
- Approval of 1,500,000 share increase for the 2024 Equity Incentive Plan.
- Record date for stockholders entitled to vote is April 16, 2026.
- Board of directors recommends voting "FOR" all proposals.
Price Impact
More from KPRX